Skip to main content
. 2022 Sep 7;20:137. doi: 10.1186/s12964-022-00923-2

Table 1.

Sequences of primers used in qPCR

Gene Primer Sequence (5′->3′)
BAX F: GGCACCTCTTCCCTCCTTTCT
R: CGATGCGCTTGAGACACTCG
BCL2 F: TTCTTTGAGTTCGGTGGGGT
R: GGGCCGTACAGTTCCACAA
p21 F: GAAGAGAAACCCCCAGCTCC
R: TGACTGCATCAAACCCCACA
p53 F: TACTCCCCTGCCCTCAACAA
R: AGGAATCAGGGCCTTGAGGA
IL-1β F: TATGTGTGTGATGCAGCTGTG
R: ACTCAAATTCCACGTTGCCC
IL-6 F: CGTCACTCCAGTTGCCTTCT
R: GCCAGTACCTCCTTGCTGTT
TNF α F: TCCTACCCGTCCAAGGTCAA
R: CTCATACCAGGGCTTGGCTT
IL-10 F: CTAGGGAACGAAGCATCCAGG
R: TCAGGAGAGAGGTACCACAGG
IL-18 F: CGCACCCCAGACCGTATTTA
R: CGCTAGACCTCTAGTGAGGC
CFLAR F: CCACTTAGGAAACAGCTGCC
R: AGGCCTTGAGGCTACTGACT
CRSL1 F: TGGGCCAGTCAAAAATCAGC
R: TTCGCGGTGTTGGAAGAGTT
MALT1 F: ATGATGTGCGACGCCTATGT
R: AGCTGCCAGTTTCTTCAGGT
CARD9 F: CAGCAACTCCTGTGGCTCAT
R: GCACTCGTCCTCGTTCTCAT
NLRP3 F: CGACACTCTGACATGGACCG
R: GGCTGAGAAGAGGCTCTGAC
MAP2K1 F: ACTGGGAAAGCTTGGGATGC
R: CAGTTCCCCAACCTTCTGCT
MAP2K2 F: CGCAGGACTTCCAGGAGTTT
R: CATCTTCAGATCCGCTCGCT
MAPK8 F: GTTGGGTGCATCATGGGAGA
R: CAGGACATGGTGTTCCAAGC
MAPK14 F: GAACGTTGTTTCCTGGCACA
R: TCTTGCAGACTCTGAGGAGATTT
NFKB F: CTTCCTTCGAGCCAGTGACG
R: CCAGGAGACTTGCTGTCGTG
IKK F: GGCGGTTGACATTAGCACAG
R: CTGAAGCCGAACCACAGTCT
NFKBIA F: CACTTCACCTTCGTGAGGCT
R: TGTCACAGGACACAACTGGG
TLR1 F: GTGAGTGGTGCCATTATGAG
R: CGCGTTTAGATTCAGGTC
TLR2 F: TCGCCGGGACTCTCTTTCTC
R: GGCCTTGAGGTTCACACACT
TLR3 F: GACTGATGCTCCGAAGGGTG
R: GGTTTGCGTGTTTCCAGAGC
PGC1A F: GGCCTTCTAAACGTGGGACA
R: CCGGAGGTCTGCCATTTTCT
FIS1 F: GGTGCGAAGCAAGTACAACG
R: GTTGCCCACAGCCAGATAGA
MFN1 F: AAGTGGCATTTTTCGGCAGG
R: TCCATATGAAGGGCATGGGC
MFN2 F: AGGTGAAGTCAGAATTGGTGGA
R: CTTCACAGGGGTGGCATCAT
Parkin F: TCCCAGTGGAGGTCGATTCT
R: CCCTCCAGGTGTGTTCGTTT
PINK1 F: GCACAATGAGCCAGGAGCTA
R: GGGGTATTCACGCGAAGGTA
GAPDH F: GATGCCCCAATGTTTGTGA
R: AAGCAGGGATGATGTTCTGG

BAX BCL-2-associated X protein, BCL-2 B-cell lymphoma 2, p21 cyclin-dependent kinase inhibitor 1A, p53 tumor suppressor p53, IL-1β Interleukin1β, IL-6 Interleukin 6, TNFα tumor necrosis factor, IL-10 interleukin 10, IL-18 interleukin 18, CFLAR CASP8 and FADD-like apoptosis regulator, CRSL1 cardiolipin synthase 1, MALT1 mucosa-associated lymphoid tissue lymphoma translocation protein 1, CARD9 Caspase recruitment domain-containing protein 9, NLRP3 NLR family pyrin domain containing 3, MAP2K1 dual specificity mitogen-activated protein kinase kinase 1, MAP2K2 mitogen-activated protein kinase kinase 2, MAPK8 mitogen-activated protein kinase 8, MAPK14: mitogen-activated protein kinase 14, NFKB nuclear factor kappa B, IKK IkappaB kinase, NFKBIA nuclear factor kappa-B inhibitor, TLR1 toll-like receptor 1, TLR2 toll-like receptor 2, TLR3 toll-like receptor 3, PGC1A peroxisome proliferator-activated receptor-gamma coactivator, FIS1 mitochondrial fission 1 protein, MFN1 mitofusin-1, MFN2 mitofusin-2, MFF mitochondrial fission factor, PARKIN E3 ubiquitin ligase parkin, PINK1 PTEN induced kinase 1, GAPDH glyceraldehyde 3-phosphate dehydrogenase